Vogenx, Inc. (VOGX)
NASDAQ: VOGX · Real-Time Price · USD
23.65
+0.49 (2.12%)
At close: Aug 20, 2026, 4:00 PM EDT
23.30
-0.35 (-1.48%)
After-hours: Aug 20, 2026, 7:30 PM EDT
Vogenx Market Cap
Vogenx has a market cap or net worth of $329.15 million as of August 20, 2026.
Market Cap
329.15M
Enterprise Value
329.74M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.65
ChartMarket Cap Chart
Since the IPO on August 12, 2026, Vogenx's market cap has increased from $180.77M to $329.15M, an increase of 82.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 329.15M | 2.12% |
| Aug 19, 2026 | 322.33M | 17.27% |
| Aug 18, 2026 | 274.87M | 25.40% |
| Aug 17, 2026 | 219.20M | 6.56% |
| Aug 14, 2026 | 205.70M | 4.90% |
| Aug 13, 2026 | 196.10M | 8.48% |
| Aug 12, 2026 | 180.77M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 276.53M |
| Adagene | 274.62M |
| Lineage Cell Therapeutics | 269.35M |
| Whitehawk Therapeutics | 269.08M |
| Sol-Gel Technologies | 268.51M |
| Conexeu Sciences | 267.58M |
| Sionna Therapeutics | 264.94M |
| YD Bio | 263.35M |